AAM
HZNP

Advisors Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Advisors Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,367
Closed -$390K – 1460
2023
Q3 		$390K Sell
3,367
-604
-15% -$64.9K 0.01% 965
2023
Q2 		$408K Sell
3,971
-592
-13% -$62.5K 0.01% 988
2023
Q1 		$498K Sell
4,563
-210
-4% -$23.2K 0.01% 939
2022
Q4 		$543K Buy
4,773
+1,529
+47% +$127K 0.01% 905
2022
Q3 		$201K Buy
3,244
+477
+17% +$33.3K ﹤0.01% 1144
2022
Q2 		$221K Buy
2,767
+813
+42% +$77K ﹤0.01% 1145
2022
Q1 		$206K Buy
1,954
+404
+26% +$39.4K ﹤0.01% 1228
2021
Q4 		$167K Buy
1,550
+928
+149% +$101K ﹤0.01% 1281
2021
Q3 		$68K Buy
622
+304
+96% +$31.6K ﹤0.01% 1337
2021
Q2 		$30K Sell
318
-772
-71% -$71K ﹤0.01% 1376
2021
Q1 		$100K Sell
1,090
-519
-32% -$43.8K ﹤0.01% 1335
2020
Q4 		$118K Sell
1,609
-875
-35% -$65K ﹤0.01% 1332
2020
Q3 		$193K Buy
+2,484
New +$171K ﹤0.01% 1190

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Advisors Asset Management's HZNP Position: Q4 2023 in Review

Advisors Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,367 shares — an estimated $390K sold.

Advisors Asset Management first reported a position in HZNP in Q3 2020 and held it in 13 quarters. The position peaked at $543K in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Advisors Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Advisors Asset Management sold 3,367 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $390K.
  • Advisors Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 13 quarters.
  • Advisors Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $543K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Advisors Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.